TILT Biotherapeutics in a $25.6 million Series B funding led by EIC Fund, Lifeline Ventures, Finnish Industry Investment TESI, and Stephen Industries
02 May 2025
02 May 2025
Total investments received (USD): 62.39M
Round value (USD): 25.6M
Company: TILT Biotherapeutics
Industry: BiotechHealth services
Related deals
Arthex Biotech in a series B extension led by Bpifrance, now totalling $87 million
Investments
06 September 2025
Highlight Therapeutics raises €22.6M with Advent Life Sciences, Columbus Venture Partners in Spain
Investments
04 September 2025
Alchemab raised $32m in Series A extension funding from OVI, RA Capital, SV Health Investors, DCVC Bio , Lightstone Ventures, and Eli Lilly.
Investments
03 September 2025
AMSilk raised €22m in debt and €30m in post series C equity funding led by Athos, joined by insiders MIG Capital and Novo Holdings.
Investments
01 September 2025
Ketryx closed a $39 million Series B round led by Transformation Capital, joined by Lightspeed Venture, MIT’s E14 Fund, Ubiquity Ventures, and 53 Stations.
Investments
29 August 2025
Netherlands
Switzerland
Estonia
Iceland
Latvia
Lithuania
Ireland
Italy
Portugal